Taychert Madison T, Serrell Emily C, Gralnek Dan, Manakas Christopher, Knoedler Margaret, Antar Ali, Santiago Javier, Grimes Matthew D
Department of Urology, University of Wisconsin, 600 Highland Avenue, Madison, WI, USA.
Transl Androl Urol. 2025 Aug 30;14(8):2337-2345. doi: 10.21037/tau-2025-256. Epub 2025 Aug 26.
Holmium laser enucleation of the prostate (HoLEP) is a bladder outlet obstruction procedure used for the treatment of benign prostatic hyperplasia (BPH). While early postoperative complications and outcomes are reported, data regarding the incidence and management of delayed urethral complications (UC), including bladder neck contracture (BNC) and urethral stricture disease (USD) are limited. We aim to define the incidence and outcomes of patients with UC following HoLEP.
A retrospective chart review was performed for 1,374 patients operated on between 07/2020-12/2023. We defined the occurrence of BNC or USD as requiring surgical treatment postoperatively. Current procedural terminology (CPT) codes were utilized to identify patients who underwent direct vision internal urethrotomy, cystoscopy with urethral dilation, urethroplasty, meatotomy, or incision of BNC. UC patients were compared to available patient metrics from our prospectively maintained database. Mann-Whitney tests, Fisher exact tests, and logistic regression were performed in GraphPad Prism version 10.3.1.
Of 1,374 patients, 20 (1.5%) had a UC postoperatively, including 14 BNC (70%), 3 USD (15%), and 3 who had both BNC and USD (15%). UC patients had significantly lower prostate volumes, surgical specimen weights, lesser enucleation and morcellation times than those without UC (P<0.05), while morcellation and enucleation efficiency were not. Logistic regression resulted in an odds ratio (OR) of 0.987 [95% confidence interval (CI): 0.974-0.997]. Presentation of UC occurred at a mean 148 days (range, 75-205 days) after surgery, with 10 (50%) of patients needing multiple surgical treatments for UC. Fifteen (75%) UC patients had a postoperative urinary tract infection (UTI) defined by presence of positive urinalysis, symptoms, and prescription of antibiotics.
We find that UC after HoLEP occurs with a low incidence of 1.5% and is associated with smaller prostate volume. We also characterize a complicated postoperative course for these patients, marked by high UTI rates and need for multiple UC surgeries. Further investigation into potential pathophysiologic mechanisms driving the association between small prostate volume and UC after HoLEP.
钬激光前列腺剜除术(HoLEP)是一种用于治疗良性前列腺增生(BPH)的膀胱出口梗阻手术。虽然已报道了早期术后并发症和结果,但关于延迟性尿道并发症(UC)的发生率和管理的数据有限,包括膀胱颈挛缩(BNC)和尿道狭窄疾病(USD)。我们旨在确定HoLEP术后UC患者的发生率和结局。
对2020年7月至2023年12月期间接受手术的1374例患者进行回顾性病历审查。我们将BNC或USD的发生定义为术后需要手术治疗。使用当前程序术语(CPT)代码来识别接受直视内部尿道切开术、尿道扩张膀胱镜检查、尿道成形术、尿道口切开术或BNC切开术的患者。将UC患者与我们前瞻性维护数据库中的可用患者指标进行比较。在GraphPad Prism 10.3.1版本中进行Mann-Whitney检验、Fisher精确检验和逻辑回归。
在1374例患者中,20例(1.5%)术后发生UC,包括14例BNC(70%)、3例USD(15%)和3例同时患有BNC和USD的患者(15%)。UC患者的前列腺体积、手术标本重量、剜除和粉碎时间明显低于无UC的患者(P<0.05),而粉碎和剜除效率则不然。逻辑回归得出的优势比(OR)为0.987 [95%置信区间(CI):0.974-0.997]。UC的出现平均发生在术后148天(范围75-205天),10例(50%)患者因UC需要多次手术治疗。15例(75%)UC患者术后发生尿路感染(UTI),定义为尿液分析阳性、有症状且使用了抗生素。
我们发现HoLEP术后UC的发生率较低,为1.5%,且与较小的前列腺体积有关。我们还描述了这些患者复杂的术后病程,其特点是UTI发生率高且需要多次UC手术。需要进一步研究导致HoLEP术后前列腺体积小与UC之间关联的潜在病理生理机制。